SCHEMBL26447888

SCHEMBL26447888

Fc1cnc(Nc2ccc(N3CCNCC3)cn2)nc1-c1ccc2ncsc2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK6 Q00534 13/20 0.74
▸ PIM1 P11309 5/20 0.74
▸ DYRK2 Q92630 7/20 0.71
▸ CCND1 P24385 8/20 0.67
▸ CDK4 P11802 8/20 0.67
▸ CCND3 P30281 6/20 0.67
▸ CDK2 P24941 6/20 0.65
▸ CCNT1 O60563 4/20 0.65
▸ CDK9 P50750 4/20 0.65
▸ CDK1 P06493 4/20 0.65
▸ CYP2C9 P11712 1/20 0.65
▸ CCNB1 P14635 1/20 0.65
▸ CCNE1 P24864 1/20 0.65
▸ CYP2C19 P33261 1/20 0.65
▸ CDK5 Q00535 1/20 0.65
▸ KCNH2 Q12809 1/20 0.65
▸ CDK5R1 Q15078 1/20 0.65
▸ CCNA2 P20248 6/20 0.64
▸ CDK7 P50613 2/20 0.64
▸ CCNH P51946 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29754565 0.99 CDK6 (0.73) CDK6PIM1DYRK2CCND1CDK4
Hydrochloric Acid SCHEMBL28521115 0.99 CDK6 (0.73) CDK6PIM1DYRK2CCND1CDK4
SCHEMBL26447876 0.86 DYRK2 (0.86) CDK6DYRK2CCND1CDK4CCND3
SCHEMBL29754350 0.86 DYRK2 (0.86) CDK6DYRK2CCND1CDK4CCND3
Hydrochloric Acid SCHEMBL29754482 0.85 DYRK2 (0.87) CDK6DYRK2CCND1
Hydrochloric Acid SCHEMBL26680019 0.85 DYRK2 (0.87) CDK6DYRK2CCND1
Hydrochloric Acid SCHEMBL29414485 0.84 CDK6 (0.98) CDK6PIM1DYRK2CCND1CDK4
Hydrochloric Acid SCHEMBL28586621 0.84 CDK6 (0.98) CDK6PIM1DYRK2CCND1CDK4
SCHEMBL26447969 0.84 DYRK2 (0.83) CDK6PIM1DYRK2CCND1CDK4
SCHEMBL26447882 0.84 DYRK2 (0.98) CDK6PIM1DYRK2CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4282864-A1 CDK6/DYRK2 DUAL-TARGET INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. (CN) 2023-11-29 — — EP disclosed
US-20230303553-A1 CDK6/DYRK2 DUAL-TARGET INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD. (CN) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303553-A1 CDK6/DYRK2 DUAL-TARGET INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF CDK6, DYRK2, CDK16 CDK6 1/4885PIM1 393/4885DYRK2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback